Why “Sell the News” on Seattle Genetics (SGEN)
There is an old rule of thumb from biotech investors and traders... SELL FDA APPROVALS. This is very counter-intuitive on the surface but we wanted to explain in more detail ...Read Full Story »
Posts related to ‘Hodgkin Lymphoma’
Read Full Story »
-
Categories:
- 24/7 Wall St. Wire (9946)
- Accounting (512)
- Active Trader (4407)
- Aerospace & Defense (230)
- Alternative Energy (1061)
- Analyst Calls (5078)
- Autos (1473)
- Banking & Finance (3793)
- Bankruptcy (282)
- Buffett (339)
- Calendar (421)
- Casinos & Hotels (99)
- Commodities & Metals (1360)
- Consumer Product (795)
- Corporate Governance (1996)
- Dividends & Buybacks (928)
- Earnings (4149)
- Economy (3702)
- Editor's Picks (516)
- ETFs & Mutual Funds (823)
- General (3837)
- Healthcare (1434)
- Housing (1039)
- Industrials (631)
- Infrastructure (604)
- International Markets (4172)
- Internet (2194)
- IPOs & Secondaries (1651)
- Jobs (158)
- Labor (656)
- Media (4203)
- Mergers & Acquisitions (2227)
- Oil & Gas (2576)
- Personal Finance (306)
- Politics (824)
- Polls (34)
- Regulation (1163)
- Retail (2583)
- Rumors (1093)
- Services (298)
- Special Report (376)
- Technology (3825)
- Telecom & Wireless (1693)
- Transportation (581)
- Value Investing (764)
